PDE5A and cancer: We here provide further evidence that confirms PDE5 signaling as crucial factor for the maintenance of CSCs in multiple cancer cell lines and highlights the upregulation of cGMP via PDE5 inhibition as a promising strategy to target CSC-containing tumors.